Direct oral anticoagulants and advanced liver disease: A systematic review and meta‐analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct oral anticoagulants and advanced liver disease: A systematic review and meta‐analysis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-14
DOI
10.1111/eci.13397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation
- (2020) Marina Serper et al. HEPATOLOGY
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and pharmacological characteristics of elderly patients admitted for bleeding: impact on in-hospital mortality
- (2020) Arianna Pani et al. ANNALS OF MEDICINE
- Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
- (2019) Hsin‐Fu Lee et al. Journal of the American Heart Association
- Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
- (2019) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease
- (2019) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review
- (2019) Yonghui Fu et al. American Journal of Cardiovascular Drugs
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
- (2019) Stavros V Konstantinides et al. EUROPEAN HEART JOURNAL
- Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study
- (2019) F.I. Mulder et al. THROMBOSIS RESEARCH
- Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation
- (2018) Pavel Goriacko et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
- (2018) Daniele Pastori et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis
- (2018) Amr Shaaban Hanafy et al. VASCULAR PHARMACOLOGY
- Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
- (2018) Chun‐Li Wang et al. Journal of the American Heart Association
- Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis
- (2018) Ronpichai Chokesuwattanaskul et al. DIGESTIVE AND LIVER DISEASE
- The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
- (2017) Justine Hum et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis
- (2017) Yuko Nagaoki et al. HEPATOLOGY RESEARCH
- Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation
- (2016) N. M. Intagliata et al. DIGESTIVE DISEASES AND SCIENCES
- Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation
- (2015) Daniele Pastori et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A catalogue of reporting guidelines for health research
- (2009) I. Simera et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search